Agonist activity of the 3-hydroxy metabolites of tibolone through the oestrogen receptor in the mouse N20.1 oligodendrocyte cell line and normal human astrocytes

Journal of Neuroendocrinology

Volumn 19, Issue 12, 2007, Pages 958-965

  Guzman C B ^a,b   Zhao, C ^a   Deighton collins, S ^a   Kleerekoper, M ^a   Benjamins, J A ^a   Skafar, D F ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Astrocytes; Estrogen; Estrogen receptor; Glia; Oligodendrocytes; Tibolone

Indexed keywords

3ALPHA HYDROXYTIBOLONE; 3BETA HYDROXYTIBOLONE; 4 HYDROXYTAMOXIFEN; DRUG METABOLITE; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; LIGAND; TIBOLONE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; ASTROCYTE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; EXPRESSION VECTOR; GENETIC TRANSFECTION; GLIA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NONHUMAN; OLIGODENDROGLIA; PLASMID; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

ANIMALS; ASTROCYTES; BLOTTING, WESTERN; CELL LINE; DATA INTERPRETATION, STATISTICAL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; HUMANS; MICE; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; NORPREGNENES; OLIGODENDROGLIA; PLASMIDS; RECEPTORS, ESTROGEN; RESPONSE ELEMENTS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TRANSFECTION;

EID: 36248931050     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2007.01611.x     Document Type: Article

References (50)

1. Ermst RL, Hay JW. The US economic and social costs of Alzheimer disease revisited. Am J Public Health 1994; 84: 1261-1264.
2. Genazzani AR, Pluchino N, Luisi S, Luisi M. Hum Reprod Update 2007; 13: 175-187.
3. Beyer C. Estrogen and the developing mammalian brain. Anat Embryol 1999; 199: 379-390.
4. McEwen BS, Alves SE. Estrogen actions in the central nervous system. Endocrine Rev 1999; 20: 279-307.
5. Garcia-Segura LM, Azcoitia I, Don Carlos LL. Neuroprotection by estradiol. Prog Neurobiol 2001; 63: 29-60.
6. Resnick SM, Maki PM. Effects of hormone replacement therapy on cognitive and brain aging. Ann NY Acad Sci 2001; 949: 203-214.
7. Schonknecht P, Pantel J, Klinga K, Jensen M, Hartmann T, Salbach B, Schroder J. Reduced cerebrospinal fluid estradiol levels are associated with increased beta-amyloid levels in female patients with Alzheimer's disease. Neurosci Lett 2001; 307: 122-124.
8. Leranth C, Roth RH, Elsworth JD, Naftolin F, Horvatch TL, Edmond DE Jr. Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: Implications for Parkinson's disease and memory. J Neurosci 2000; 20: 8604-8609.
9. Dluzen DE, McDermott JL. Gender differences in neurotoxicity of the nigrostriatal dopaminergic system: Implications for Parkinson's disease. J Gen Specif Med 2000; 3: 36-42.
10. Turgeon JL, Carr MC, Maki PM, Mendelsohn ME, Wise PM. Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: insights from basic science and clinical studies. Endocrine Rev 2006; 27: 575-605.
11. Modelska K, Cummings S. Tibolone for postmenopausal women: Systematic review of randomized clinical trials. J Clin Endocrinol Metabolism 2002; 87: 16-23.
12. Moore RA. Livial: A review of clinical studies. Br J Obstet Gynaecol 1999; 6 (Suppl. 190): 1-21.
13. Kloosterboer HJ, Ederveen AG. Pros and cons of existing treatment modalities in osteoporosis comparison between tibolone, SERMs and estrogen (+/- progestogen) treatments. J Steroid Biochem Mol Biol 2002; 83: 1844-1854.
14. Paganini-Hill A, Henderson VW. Estrogen replacement therapy and the risk of Alzheimer disease. Arch Intern Med 1996; 156: 2213-2217.
15. Wise PM, Dubal DB, Wilson ME, Rau SW, Liu Y. Estrogens: Trophic and protective factors in the adult brain. Front Neuroendocrinol 2001; 22: 33-66.
16. Goodman Y, Bruce AJ, Cheng B, Mattson MP. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons. J Neurochem 1996; 66: 1836-1844.
17. Behl C. Oestrogen as a neuroprotective hormone. Nat Rev Neurosci 2002; 3: 433-442.
18. Garcia Ovejero D, Veiga S, Garcia-Segura LM, Doncarlos LL. Glial expression of estrogen and androgen receptors after rat brain injury. J Comp Neurol 2002; 26: 256-271.
19. Zhang Z, Cerghet M, Mullins Ch, Williamson M, Bessert D, Skoff R. Comparison of in vivo and in vitro subcellular localization of estrogen receptors α and β in oligodendrocytes. J Neurochem 2004; 89: 674-684.
20. Pawlak J, Karolczak M, Krust A, Chambon P, Beyer C. Estrogen receptor-alpha is associated with the plasma membrane of astrocytes and coupled to the MAP/Src-kinase pathway. Glia 2005; 50: 270-275.
21. Viviani B, Corsini E, Binaglia M, Lucchi L, Galli CL, Marinovich M. The anti-inflammatory activity of estrogen in glial cells is regulated by the PKC-anchoring protein RACK-1. J Neurochem 2002; 83: 1180-1187.
22. Amantea D, Russo R, Bagetta G, Corasaniti MT. From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens. Pharmacol Res 2005; 52: 119-132.
23. Cui W, Allen ND, Skynner M, Gusterson B, Clark AJ. Inducible ablation of astrocytes shows that these cells are required for neuronal survival in the adult brain. Glia 2001; 34: 272-282.
24. Verity AN, Bredesen D, Vonderscher C, Handley VW, Campagnoni AT. Expression of myelin protein genes and other myelin components in an oligodendrocytic cell line conditionally immortalized with a temperature-sensitive retrovirus. J Neurochem 1993; 60: 577-587.
25. Studzinski D, Benjamins J. Expression of P0 glycoprotein in CNS glia: effects of overexpression in N20.1 cells. Glia 2005; 51: 234-244.
26. Studzinski D, Ramaswamy R, Benjamins J. Effects of cyclic AMP on expression of myelin genes in the N20.1 cell line. Neurochem Res 1998; 23: 435-441.
27. Studzinski DM, Callahan RE, Benjamins JA. Increased intracellular calcium alters myelin gene expression in the N20.1 oligodendroglial cell line. J Neurosci Res 1999; 75: 633-642.
28. Ogawa S, Inoue S, Watanabe T, Hiroi H, Orimo A, Hosoi T, Ouchi Y, Muramatsu M. The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro. Biochem Biophys Res Comm 1998; 243: 122-126.
29. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
30. Guzman CB, Deighton-Collins S, Martinez A, Kleerekoper M, Zhao Ch, Benjamins JA, Skafar DF. Activity of estradiol and selective estrogen receptor modulators in the mouse N20.1 oligodendrocyte/astrocytes cell line. Neuro Endocrinol Lett 2005; 26: 526-532.
31. Webb P, Nguyen P, Valentine C, Lopez G, Kwok GR, McInerney E, Katzenellenbogen BS, Enmark E, Gustafsson J-A, Nilsson S, Kushner PJ. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol Endocrinol 1999; 13: 1672-1685.
32. Webb P, Lopez GN, Uth RM, Kushner PJ. Tamoxifen activation of estrogen receptor/AP-1 pathway: Potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 1995; 9: 443-456.
33. Pettersson K, Gustafsson JA. Role of estrogen receptor beta in estrogen action. Annu Rev Physiol 2001; 63: 165-192.
34. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, Scanlan TS. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 1997; 277: 1508-1510.
35. de Gooyer ME, Oppers-Tiemissen HM, Leysen D, Verheul HA, Kloosterboer HJ. Tibolone is not converted by human aromatase to 7alpha-methyl-17alpha-ethynylestradiol (7alpha-MEE). analyses with sensitive bioassays for estrogens and androgens and with LC-MSMS. Steroids 2003; 68: 235-243.
36. Maharjan S, Scrova L, Sabban EL. Transcriptional regulation of tyrosine hydroxylase by estrogen: Opposite effects with estrogen receptors α and β and interactions with cyclic AMP. J Neurochem 2005; 93: 1502-1514.
37. Hosli E, Ruhl W, Hosli L. Histochemical and electrophysiological evidence of estrogen receptors on cultured astrocytes: Colocalization with cholinergic receptors. Inst J Dev Neurosci 2000; 18: 101-111.
38. Garcia-Segura LM, Naftolin F, Hutchinson JB, Azcotia I, Chowen JA. Role of astroglia in estrogen regulation of synaptic plasticity and brain repair. J Neurobiol 1999; 40: 574-584.
39. Mong JA, Glaser E, McCarthy MM. Gonadal steroids promote glial differentiation and alter neuronal morphology in the developing hypothalamus in a regionally specific manner. J Neurosci 1999; 19: 1464-1472.
40. Dhandapani KM, Brann DW. Neuroprotective effects of estrogen and tamoxifen in vitro. Endocrine 2003; 21: 59-66.
41. Buchanan CD, Mahesh VB, Brann DW. Estrogen-astrocyte-luteinizing hormone-releasing hormone signaling: A role for transforming growth factor β1. Biol Reprod 2000; 62: 1710-1721.
42. Duenas M, Luquin S, Chowen JA, Torres-Aleman I, Naftolin F, Garcia-Segura LM. Gonadal hormone regulation of insulin-like growth factor-I-like immunoreactivity in hypothalamic astroglia of developing and adult rats. Neuroendocrinology 1994; 59: 528-538.
43. Lu YP, Zeng M, Hu XY, Xu H, Swaab DF, Ravid R, Zhou JN. Estrogen receptor α-immunoreactive astrocytes are increased in hippocampus in Alzheimer's disease. Exp Neurol 2003; 183: 482-488.
44. Savaskan E, Olivieri G, Meier F, Ravid R, Muller-Spahn F. Hippocampal estrogen β-receptor immunoreactivity is increased in Alzheimer's disease. Brain Res 2001; 908: 113-119.
45. Platania P, Laureanti F, Bellomo M, Giuffrida R, Giuffrida-Stella AM, Catania MV, Sortino MA. Differential expression of estrogen receptors alpha and beta in the spinal cord during postnatal development: localization in glial cells. Neuroendocrinology 2003; 77: 334-340.
46. Stone DJ, Song Y, Anderson CP, Khron KK, Finch CE, Rozovsky I. Bidirectional transcriptional regulation of glial fibrillary acidic protein by estradiol in vivo and in vitro. Endocrinology 1998; 139: 3202-3209.
47. Azcoitia I, Sierra A, Garcia-Segura LM. Localization of estrogen receptor-β immunoreactivity in astrocytes of the adult rat brain. Glia 1999; 26: 260-267.
48. Dhandapani KM, Brann DW. Estrogen-astrocyte interactions: Implications for neuroprotection. BMC Neuroscience 2002; 3: 6.
49. Sortino MA, Chisari M, Merlo S, Vancheri C, Caruso M, Nicoletti F, Canonico PL, Copani A. Glia mediates the neuroprotective action of estradiol on β-amyloid-induced neuronal death. Endocrinology 2004; 145: 5080-5086.
50. Vincent B, Smith JD. Effect of estradiol on neuronal Swedish-mutated β-amyloid precursor protein metabolism: Reversal by astrocytic cells. Biochem Biophys Res Comm 2000; 271: 82-85.